Consumer

The Society urges collaboration between clinicians and technologists, and healthcare organizations to use the tech to assist the clinical workforce, not replace it. 

Sanofi invests in Zucara Therapeutics and MintNeuro raises $1.27 million in a funding round.

HCA members will have access to and support for MGI's single cell and spatial omics technologies.

Adam Hutchinson, oVRcome founder and CEO, discusses reducing phobias using VR exposure therapy, how the company fills the gap in VR psychiatric care access for providers and patients, and its trial on combatting social anxiety with VR.

The acquisition includes all of NeuroReality's assets, including its flagship rehabilitation product, Koji's Quest.

Attorney Everett Wilson, managing partner at Polsinelli's Miami office, discusses overall changes in Medicare and Medicare Advantage - and how the recent benefits changes affect consumers, payers and plans.

The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of Novo Nordisk's GLP-1 drug on its platform in 2025.

The company offers a marketplace for individuals seeking addiction and mental health treatment. It will use the funds to scale its workforce and expand its reach.